Growth and differentiation of embryonal carcinoma cell line F9 in defined media.
This paper reports the growth and differentiation of the mouse embryonal carcinoma cell line F9 in completely defined culture media. The defined growth medium, referred to as EM-3, contains plasma fibronectin, insulin, and transferrin in place of serum. F9 cells cultured in EM-3 for over 15 generations retain their ability to form tumors and to differentiate. Fibronectin is essential for the attachment of F9 cells in defined media and its effect can be blocked with affinity-purified anti-fibronectin. When retinoic acid was added to EM-3, the F9 cells differentiated. The majority of the the newly formed cells differed from patient F9 cell two major respects: (i) they were morphologically different; and (ii) they secreted plasminogen activator, and the secretion was stimulated by dibutyrlyl adenosine cyclic monophosphate.
D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D003470:Culture Media; D005353:Fibronectins / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology; D051379:Mice; D009374:Neoplasms, Experimental / Q000473:pathology; D010960:Plasminogen Activators / Q000378:metabolism; D013724:Teratoma / Q000473:pathology*; D014168:Transferrin / Q000494:pharmacology; D014212:Tretinoin / Q000494:pharmacology
D003470:Culture Media; D005353:Fibronectins; D007328:Insulin; D014168:Transferrin; D014212:Tretinoin; D003994:Bucladesine; D010960:Plasminogen Activators